capaDATA
  • PERFORMANCE
    • Younger saver, 30 years to retirement – 5-year annualised returns
      • Line chart
      • Bar chart
    • Younger saver, 30 years to retirement – 3-year annualised returns
      • Line chart
      • Bar chart
    • Younger saver, 30 years to retirement – 1-year annualised returns
      • Line chart
      • Bar chart
    • Older saver, 5 years to retirement – 5-year annualised returns
      • Line chart
      • Bar chart
    • Older saver, 5 years to retirement – 3-year annualised returns
      • Line chart
      • Bar chart
    • Older saver, 5 years to retirement – 1-year annualised returns
      • Line chart
      • Bar chart
  • RISK/RETURN
    • Risk/Return – Younger saver, 30 years from retirement, 5-year annualised
    • Risk/Return – Younger saver, 30 years from retirement, 3-year annualised
    • Risk/Return – Younger saver, 30 years from retirement, 1-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 5-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 3-year annualised
    • Risk/Return – Older saver, 5 years from retirement, 1-year annualised
  • PROVIDERS
    • Aegon Master Trust
    • Aon Master Trust
    • Atlas Master Trust
    • Aviva Master Trust
    • The Bluesky Pension Scheme
    • Ensign Retirement Plan
    • Fidelity Master Trust
    • Legal & General Investment Management – WorkSave Pension Mastertrust
    • LifeSight (Willis Towers Watson)
    • Mercer Master Trust
    • National Employment Savings Trust (NEST)
    • Now: Pensions
    • The People’s Pension
    • Salvus Master Trust
    • Scottish Widows Master Trust
    • Smart Pension
    • Standard Life DC Master Trust
    • SuperTrust UK Master Trust
    • TPT Retirement Solutions
    • Welplan Pensions
  • Research
    • ADVISERS
      • Pension provider selection factors
      • Switching
      • Diversification
      • Illiquids
      • ESG
      • Green
      • Digital
      • Consolidation
    • PROVIDERS
      • Master Trusts by number of members
      • Master Trust defaults by assets and number of employers
      • Member charges
      • Employer charges
      • Master trust investment advisers
      • Equity exposure
      • Derisking
      • Asset managers used
  • NEWS
  • MORE
    • About
    • Advertise
    • Contact us
    • Privacy policy
    • Content syndication
    • Terms & Conditions
CAPA
No Result
View All Result

2.5m cancer patients face extra costs due to diagnosis- research

04 February 2022
WPA extends choice for intermediaries and their customers
Share on TwitterShare on FacebookShare on LinkedIn

More than four out of every five cancer patients, equivalent to 2.5m people, in the UK face additional costs of about £900 per month due to cancer diagnosis, according to data from Macmillan Cancer Support.

Macmillan found that extra costs can arise from a variety of supplementary and frequently unexpected needs, as well as a decrease in earnings if people are unable to work.

Cancer was the most common reason for critical illness claims made by both female (75 per cent) and male (52 per cent) customers in 2020, according to separate data from Scottish Widows. In that year, the company paid out £81m in critical illness claims, with the average claim totalling £55,182.

Another research from Scottish Widows found that about 26 per cent of persons with cancer or living with someone who had been diagnosed would have found advice on obtaining government benefits and other forms of financial assistance beneficial.

Scottish Widows has partnered with Macmillan Cancer Support which allows life, pensions, and investments policyholders to be directed to Macmillan’s Support Line for a variety of expert help. Scottish Widows says the partnership has sped up the critical illness claims procedure which has lowered the time it takes to process a claim from over 60 days to around 17 days in some circumstances.

Scottish Widows protection director Rose St Louis says: “If you’ve been diagnosed with cancer, the focus should be on your health and getting the treatment that you need. However, the reality of life means that people also often have to worry about money, and the time taken to access the medical care that they need. 

“Our partnership with Macmillan Cancer Support aims to address these issues in a very real way, to help policyholders prioritise their health. The training we’re giving to line managers also means that colleagues are provided with the help and support they need during what can be a very difficult time.”

The post 2.5m cancer patients face extra costs due to diagnosis- research appeared first on Corporate Adviser.

TweetShareShare
Previous Post

Health of UK DB schemes reaches new high as rates rise again

Next Post

Scottish Widows publishes roadmap to net-zero

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Category

  • By Provider
  • News
  • Not for search
  • Provider page archive
  • Uncategorized
  • video
CAPA data

© 2019 Definite Article Media Limited. Design by Bedazzled Media Limited.

  • About
  • Advertise
  • Contact us
  • Privacy policy
  • Syndication

Follow us

No Result
View All Result
  • About
  • Advertise
  • Contact us
  • Privacy policy
  • Syndication

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT